Scripps Research Institute
General
Total Cases11
Active Cases4
Patents422
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
L2
B
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Dexcel and Aurobindo's First Set of Common Requests for the Production of Documents and Things (Nos. 1-7) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Asserted Claims and Infringement Contentions for Zenara's ANDA Product filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 08/29/24 | Pro Hac Vice Attorney Emer L. Simic for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 08/29/2024) | |
| 08/26/24 | SO ORDERED, D.I. [99] Amended Stipulation and Order Further Amending the Scheduling Order filed by Zenara Pharma Private Limited. Ordered by Judge Christopher J. Burke on 8/26/2024. (mpb) Modified on 8/26/2024 (smg). (Entered: 08/26/2024) | |
| 08/20/24 | Amended STIPULATION Stipulation and [PROPOSED] Order Further Amending the Scheduling Order re [22] Scheduling Order,,,,, by Zenara Pharma Private Limited. (Gattuso, Dominick) (Entered: 08/20/2024) | |
| 08/02/24 | NOTICE OF SERVICE of Defendants Aurobindo and Dexcel's First Set of Common Requests for Production to Plaintiffs (Nos. 1-7) filed by Aurobindo Pharma Limited.(Dorsney, Kenneth) (Entered: 08/02/2024) | |
| 07/22/24 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Dexcel's First Set of Individual Requests for the Production of Documents and Things (Nos. 1- 19); and (2) Plaintiffs' Objections and Responses to Dexcel Pharma Technologies Limited's First Set of Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/22/2024) | |
| 07/19/24 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Common Requests for the Production of Documents and Things (Nos. 1-141) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/19/2024) | |
| 07/17/24 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/17/2024) | |
| 07/15/24 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Zenara's First Set of Interrogatories (No. 1); and (2) Plaintiffs' Responses and Objections to Zenara's First Set of Requests for the Production of Documents and Things (No. 1) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/15/2024) |